CV Sciences, Inc.(Other OTC/NBB : CANV)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Loading CANV News...
Consumer Services » Other Consumer Services
|PCLN||Priceline Group Inc||0.17%||1649.80||2.6%||$648.39m|
|CTRP||Ctrip.com International Ltd Sponsored ADR||1.23%||47.64||4.9%||$152.99m|
|EDU||New Oriental Education & Technology Group, Inc. Sponsored ADR||0.79%||49.56||1.3%||$53.16m|
|HRB||H&R Block, Inc.||-0.90%||20.42||8.2%||$52.28m|
|SCI||Service Corporation International||0.00%||31.64||4.4%||$43.84m|
|SERV||ServiceMaster Global Holdings Inc||0.36%||38.81||4.2%||$25.58m|
|DV||DeVry Education Group Inc.||-0.46%||32.70||16.4%||$25.16m|
|BID||Sotheby's Class A||-1.07%||40.67||16.2%||$18.08m|
|LOPE||Grand Canyon Education, Inc.||0.59%||61.27||2.6%||$17.13m|
|PLNT||Planet Fitness Inc Class A||-1.11%||21.41||8.7%||$16.82m|
CV Sciences, Inc. is a life science company, which develops, produces, markets and sells raw materials and end consumer products containing the hemp plant extract, Cannabidiol (CBD) to the nutraceutical, beauty care, pet care, specialty beverage and functional food sectors. The company operates its business through two segments: Specialty Pharmaceuticals and Consumer Products. The Specialty Pharmaceuticals segment is focused on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol. The Consumer Products segment engages in the manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The company was founded by H. J. Cole on December 9, 2010 and is headquartered in Las Vegas, NV.